In a study by El Sherbini et al., 40% of stage I/II ovarian cancer patients (n = 10-15) presented above normal levels of KLK6 while 83.3% of stage III/IV patients (n = 12) were KLK6 positive [19]. Here, KLK6 is linked to ovarian carcinoma.